Evelyn Du

1.8k total citations · 1 hit paper
19 papers, 1.2k citations indexed

About

Evelyn Du is a scholar working on Psychiatry and Mental health, Neurology and Epidemiology. According to data from OpenAlex, Evelyn Du has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Neurology and 5 papers in Epidemiology. Recurrent topics in Evelyn Du's work include Traumatic Brain Injury and Neurovascular Disturbances (5 papers), Migraine and Headache Studies (4 papers) and Intracranial Aneurysms: Treatment and Complications (3 papers). Evelyn Du is often cited by papers focused on Traumatic Brain Injury and Neurovascular Disturbances (5 papers), Migraine and Headache Studies (4 papers) and Intracranial Aneurysms: Treatment and Complications (3 papers). Evelyn Du collaborates with scholars based in United States, Germany and Denmark. Evelyn Du's co-authors include E. Sander Connolly, Stephan A. Mayer, Kurt T. Kreiter, Jan Claassen, J. Ricardo Carhuapoma, Lawrence J. Hirsch, Ronald G. Emerson, Shelley Peery, Jan Claassen and Julia H. Arnsten and has published in prestigious journals such as Neurology, Stroke and Critical Care Medicine.

In The Last Decade

Evelyn Du

16 papers receiving 1.1k citations

Hit Papers

A phase 3 randomized safety and immunogenicity trial of m... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evelyn Du United States 10 799 184 148 114 114 19 1.2k
Michael Reznik United States 17 290 0.4× 81 0.4× 201 1.4× 140 1.2× 165 1.4× 78 747
Michael Shoykhet United States 13 211 0.3× 142 0.8× 122 0.8× 85 0.7× 52 0.5× 25 672
Markus Harboe Olsen Denmark 13 280 0.4× 133 0.7× 93 0.6× 71 0.6× 58 0.5× 97 629
Patricio S Espinosa United States 14 665 0.8× 59 0.3× 57 0.4× 49 0.4× 161 1.4× 35 1.1k
Hans-Christian Hansen Germany 9 632 0.8× 146 0.8× 84 0.6× 48 0.4× 47 0.4× 40 852
Hans‐Peter Haring Austria 17 435 0.5× 110 0.6× 613 4.1× 126 1.1× 181 1.6× 27 1.2k
Dominik Madžar Germany 17 398 0.5× 110 0.6× 259 1.8× 36 0.3× 176 1.5× 46 707
Neus Fàbregas Spain 15 437 0.5× 117 0.6× 201 1.4× 185 1.6× 72 0.6× 84 951
Kristine O’Phelan United States 14 689 0.9× 124 0.7× 352 2.4× 65 0.6× 56 0.5× 35 962
Daniel B. Michael United States 16 419 0.5× 160 0.9× 190 1.3× 62 0.5× 25 0.2× 28 897

Countries citing papers authored by Evelyn Du

Since Specialization
Citations

This map shows the geographic impact of Evelyn Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelyn Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelyn Du more than expected).

Fields of papers citing papers by Evelyn Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evelyn Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelyn Du. The network helps show where Evelyn Du may publish in the future.

Co-authorship network of co-authors of Evelyn Du

This figure shows the co-authorship network connecting the top 25 collaborators of Evelyn Du. A scholar is included among the top collaborators of Evelyn Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evelyn Du. Evelyn Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Soens, Mieke, Jintanat Ananworanich, Kathryn Jean Lucas, et al.. (2025). A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults. Vaccine. 50. 126847–126847. 18 indexed citations breakdown →
2.
Soens, Mieke, Boris Kandinov, Daniela Ramirez‐Schrempp, et al.. (2023). 1639. A Review of Clinical Safety, Reactogenicity, and Immunogenicity of an mRNA-Based Seasonal Influenza Vaccine (mRNA-1010) in Adults. Open Forum Infectious Diseases. 10(Supplement_2). 3 indexed citations
3.
Gladstone, Jonathan P., Hans‐Christoph Diener, Xiaoping Ning, et al.. (2021). Efficacy in Patients Switching from Quarterly to Monthly Fremanezumab or Maintained on Monthly Fremanezumab Treatment Over 6 Months in the Phase 3b FOCUS Study (2124). Neurology. 96(15_supplement).
4.
Silberstein, Stephen D., Joshua M. Cohen, Ronghua Yang, et al.. (2021). Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials. The Journal of Headache and Pain. 22(1). 2–2. 8 indexed citations
5.
7.
Ashina, Messoud, Joshua M. Cohen, Sanjay Gandhi, & Evelyn Du. (2021). Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine. Headache The Journal of Head and Face Pain. 61(6). 916–926. 4 indexed citations
8.
Virchow, J. Christian, Lisa Hickey, Evelyn Du, & Margaret Garin. (2020). In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV1 reversibility. Allergy Asthma and Clinical Immunology. 16(1). 26–26. 4 indexed citations
9.
Corren, Jonathan, et al.. (2020). Variability in Blood Eosinophil Counts in Patients with Eosinophilic Asthma. The Journal of Allergy and Clinical Immunology In Practice. 9(3). 1224–1231.e9. 25 indexed citations
10.
Asgary, Ramin, et al.. (2008). Teaching Residents to Work with Torture Survivors: Experiences from the Bronx Human Rights Clinic. Journal of General Internal Medicine. 23(7). 1038–1042. 13 indexed citations
11.
Delaney, Jessica, Gregory C. Janis, Ricardo Bello, et al.. (2008). The Impact of Co-Morbid Peripheral Vascular Disease on Mortality in a Racially Balanced Cohort with Congestive Heart Failure. Journal of Cardiac Failure. 14(6). S83–S83. 1 indexed citations
13.
Kunins, Hillary V., Eran Bellin, Cynthia Chazotte, Evelyn Du, & Julia H. Arnsten. (2007). The Effect of Race on Provider Decisions to Test for Illicit Drug Use in The Peripartum Setting. Journal of Women s Health. 16(2). 245–255. 76 indexed citations
14.
Claassen, Jan, A. T. Vu, Kurt T. Kreiter, et al.. (2004). Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage*. Critical Care Medicine. 32(3). 832–838. 155 indexed citations
15.
Claassen, Jan, Lawrence J. Hirsch, Kurt T. Kreiter, et al.. (2004). Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clinical Neurophysiology. 115(12). 2699–2710. 266 indexed citations
16.
Sahlein, Daniel H., Éric Heyer, Anita Rampersad, et al.. (2003). Failure of Intraoperative Jugular Bulb S-100B and Neuron-Specific Enolase Sampling to Predict Cognitive Injury after Carotid Endarterectomy. Neurosurgery. 53(6). 1243–1250. 28 indexed citations
17.
Claassen, Jan, Shelley Peery, Kurt T. Kreiter, et al.. (2003). Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology. 60(2). 208–214. 148 indexed citations
18.
Claassen, Jan, J. Ricardo Carhuapoma, Kurt T. Kreiter, et al.. (2002). Global Cerebral Edema After Subarachnoid Hemorrhage. Stroke. 33(5). 1225–1232. 394 indexed citations
19.
Kreiter, Kurt T., Jan Claassen, Axel J. Rosengart, et al.. (2001). Influence of Depression on Return to Work after Subarachnoid Hemorrhage. Stroke. 32. 338–338. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026